News
Glucagon intravenous for adults
Who can administer
May be administered by registered competent doctor or nurse/midwife
Important information
- Usually given by the subcutaneous or intramuscular route for the treatment of severe hypoglycaemia reactions
- Please ensure additional supplies are ordered by pharmacy if large doses by infusion are being administered
- Protect the airway in case of vomiting (ref 2)
- Equivalencies: a 1mg dose is the same as 1 unit
Available preparations
Glucagen Hypokit 1mg
Reconstitution
- Add 1.1mL water for injection (provided) to the vial containing the powder to produce a 1mg/1mL solution
- Shake gently until completely dissolved
- A syringe with a thinner needle and a finer graduation may be more suitable in diagnostic procedures
Infusion fluids
Glucose 5% or Sodium chloride 0.9% (ref 1)
Methods of intravenous administration
Bolus intravenous injection (doses of 1mg or less) (ref 1)
- Administer over one minute
- Rapid injection may be associated with increased nausea and vomiting (ref 2)
Slow intravenous injection (doses greater than 1mg) (ref 1)
- Administer over 3 to 5 minutes
- Rapid injection may be associated with increased nausea and vomiting (ref 2)
Intermittent intravenous infusion (unlicensed) (ref 1)
- There is no recommended final volume/concentration for dilution. It is usually convenient to dilute in 50 or 100mL, but larger or smaller volumes can be used if necessary
Dose in adults
Severe hypoglycaemia
- Usually 1mg, given by the subcutaneous or intramuscular route
Diagnostic indication (inhibition of gastrointestinal motility)
- Relaxation of stomach, duodenal bulb, duodenum and small bowel: 0.2 to 0.5mg as intravenous injection
- Relaxation of colon: 0.5 to 0.75mg as intravenous injection
- Higher doses may be given for these indications if by subcutaneous or intramuscular route- see SPC
Beta-blocker/calcium channel blocker toxicity (unlicensed) (ref 2)
- Consult poisons centre
- Give 3 to 10mg (0.05 to 0.15mg/kg) as a slow intravenous injection over 2 to 5 minutes, followed by an infusion of 3 to 5mg/hour (0.05 to 0.1mg/kg/hour)
- Titrate the infusion to achieve an adequate clinical response
Anaphylactic reaction (refractory) in patients on beta-blocker therapy (unlicensed) (ref 2)
- Give 1 to 5mg as a slow intravenous injection over 5 minutes, followed by an infusion of 5 to 15 micrograms/minute
- Titrate the infusion to achieve an adequate clinical response
Renal or hepatic impairment
- No dosage adjustment is required
Storage
- Store in a refrigerator between 2 and 80C - for full shelf life of product
- May be stored at room temperature for up to 18 months (providing the expiry date is not exceeded)
References
SPC December 2019
1: Injectable medicines guide - Medusa, downloaded 24th November 2021
2: Uptodate- downloaded 24th November 2021
Therapeutic classification
Glycogenolytic hormone